Literature DB >> 8222057

Allyl isothiocyanate is selectively toxic to transformed cells of the human colorectal tumour line HT29.

S R Musk1, I T Johnson.   

Abstract

Allyl isothiocyanate, a constituent of mustard and certain vegetables found in the human diet, was tested for cytotoxic and cytostatic effects in HT29 human colon carcinoma cells in vitro. For an exposure time of 24 h, allyl isothiocyanate exhibited a Dq of 0.32 microgram/ml and a D0 of 0.74 micrograms/ml. Following detransformation of the cells by treatment with sodium butyrate or dimethylformamide the cells became more resistant to the cytotoxic effects of allyl isothiocyanate, the Dq increasing to 0.74 microgram/ml and the D0 to 0.96 microgram/ml (with butyrate) or 0.84 microgram/ml (with dimethylformamide). At the Dq value for detransformed cells the survival of the control cells was reduced to 56%. Allyl isothiocyanate was also found to be less cytostatic to the mass growth of detransformed populations in that daily doses of 1.6 micrograms/ml over a week reduced the final number of detransformed cells relative to untreated cultures by < 25% whilst growth of the transformed cultures was reduced by > 60%. Given this increased sensitivity of the cells to allyl isothiocyanate when in the transformed state, it is hypothesized that, when consumed in the human diet, this compound may protect against the development of colorectal cancer by selectively inhibiting the growth of transformed cell clones within the gastrointestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8222057     DOI: 10.1093/carcin/14.10.2079

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  15 in total

1.  TRPA1 is functionally expressed in melanoma cells but is not critical for impaired proliferation caused by allyl isothiocyanate or cinnamaldehyde.

Authors:  Beatrice Oehler; Anja Scholze; Michael Schaefer; Kerstin Hill
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-03-18       Impact factor: 3.000

2.  Hydrogen sulfide protects colon cancer cells from chemopreventative agent beta-phenylethyl isothiocyanate induced apoptosis.

Authors:  Peter Rose; Philip-K Moore; Shen-Han Ming; Ong-Choon Nam; Jeffrey-S Armstrong; Matt Whiteman
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

3.  Insights into the mode of action of benzyl isothiocyanate on Campylobacter jejuni.

Authors:  Virginie Dufour; Martin Stahl; Eric Rosenfeld; Alain Stintzi; Christine Baysse
Journal:  Appl Environ Microbiol       Date:  2013-09-06       Impact factor: 4.792

4.  Synergistic effect of allyl isothiocyanate (AITC) on cisplatin efficacy in vitro and in vivo.

Authors:  Xiang Ling; David Westover; Felicia Cao; Shousong Cao; Xiang He; Hak-Ryul Kim; Yuesheng Zhang; Daniel Cf Chan; Fengzhi Li
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

Review 5.  The molecular basis that unifies the metabolism, cellular uptake and chemopreventive activities of dietary isothiocyanates.

Authors:  Yuesheng Zhang
Journal:  Carcinogenesis       Date:  2011-11-10       Impact factor: 4.944

6.  Inhibition of bladder cancer development by allyl isothiocyanate.

Authors:  Arup Bhattacharya; Li Tang; Yun Li; Feng Geng; Joseph D Paonessa; Shang Chiung Chen; Michael K K Wong; Yuesheng Zhang
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

Review 7.  Allyl isothiocyanate as a cancer chemopreventive phytochemical.

Authors:  Yuesheng Zhang
Journal:  Mol Nutr Food Res       Date:  2010-01       Impact factor: 5.914

8.  Serum glutathione transferase does not respond to indole-3-carbinol: A pilot study.

Authors:  Daniel R McGrath; Hamid Frydoonfar; Joshua J Hunt; Chris J Dunkley; Allan D Spigelman
Journal:  Ther Clin Risk Manag       Date:  2010-05-25       Impact factor: 2.423

9.  The new isothiocyanate 4-(methylthio)butylisothiocyanate selectively affects cell-cycle progression and apoptosis induction of human leukemia cells.

Authors:  Carmela Fimognari; Michael Nüsse; Renato Iori; Giorgio Cantelli-Forti; Patrizia Hrelia
Journal:  Invest New Drugs       Date:  2004-04       Impact factor: 3.850

10.  Modulation of AP-1 by natural chemopreventive compounds in human colon HT-29 cancer cell line.

Authors:  Woo-Sik Jeong; In-Wha Kim; Rong Hu; Ah-Ng Tony Kong
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.